These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 10500523

  • 1. [Initial treatment of chronic myelogenous leukemia--interferon or bone marrow transplantation].
    Urabe A.
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1381-6. PubMed ID: 10500523
    [Abstract] [Full Text] [Related]

  • 2. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
    Ohnishi K, Minami S, Ueda T, Nishimura M, Tsubaki K, Takemoto Y, Takeshita A, Sao H, Kageyama S, Ueda R, Ohno R.
    Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
    [Abstract] [Full Text] [Related]

  • 3. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A.
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
    [Abstract] [Full Text] [Related]

  • 4. Absence of influence of prior treatment with interferon on the outcome of allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Tomás JF, López-Lorenzo JL, Requena MJ, Aguilar R, Steegmann JL, Cámara R, Alegre A, Arranz R, Figuera A, Fernández-Rañada JM.
    Bone Marrow Transplant; 1998 Jul; 22(1):47-51. PubMed ID: 9678795
    [Abstract] [Full Text] [Related]

  • 5. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
    Beksac M, Celebi H, Sargín D, Yalcin A, Topcuoglu P, Kalayoglu-Besisik S, Beyan C, Arslan O, Ozcan M, Gurman G, Ilhan O, Akan H.
    Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
    [Abstract] [Full Text] [Related]

  • 6. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
    Xu L, Guo N, Huang X.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
    [Abstract] [Full Text] [Related]

  • 7. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
    Maeda A, Yamamoto K, Kotone Y, Yamashita K, Yoshinaga N, Hirata H, Asagoe K, Nohgawa M, Takahashi A, Ohno H, Tashima M, Sasada M.
    Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
    [Abstract] [Full Text] [Related]

  • 8. Chronic myelogenous leukemia: state of the art.
    Polli EE, Pozzoli E, Annaloro C.
    Ann Ital Med Int; 1991 Jun; 6(4 Pt 2):491-7. PubMed ID: 1840816
    [Abstract] [Full Text] [Related]

  • 9. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
    Yao B, Guo M, Pian H.
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
    [Abstract] [Full Text] [Related]

  • 10. Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data.
    Kantarjian HM, O'Brien S, Cortes J, Giles FJ, Rios MB, Shan J, Faderl S, Garcia-Manero G, Ferrajoli A, Verstovsek S, Wierda W, Keating M, Talpaz M.
    Cancer; 2003 Dec 15; 98(12):2636-42. PubMed ID: 14669283
    [Abstract] [Full Text] [Related]

  • 11. [Developments in the treatment of patients with chronic myeloid leukemia].
    Cornelissen JJ, Löwenberg B.
    Ned Tijdschr Geneeskd; 1997 Oct 04; 141(40):1904-9. PubMed ID: 9550736
    [Abstract] [Full Text] [Related]

  • 12. Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
    Kantarjian HM, Talpaz M, O'Brien S, Smith TL, Giles FJ, Faderl S, Thomas DA, Garcia-Manero G, Issa JP, Andreeff M, Kornblau SM, Koller C, Beran M, Keating M, Rios MB, Shan J, Resta D, Capdeville R, Hayes K, Albitar M, Freireich EJ, Cortes JE.
    Clin Cancer Res; 2002 Jul 04; 8(7):2177-87. PubMed ID: 12114418
    [Abstract] [Full Text] [Related]

  • 13. [Molecular implication of Ph positive leukemias: treatment with alpha-interferon in Ph positive acute leukemia].
    Ohyashiki JH, Kawakubo K, Ohyashiki K, Toyama K.
    Rinsho Byori; 1993 Dec 04; 41(12):1305-9. PubMed ID: 8295339
    [Abstract] [Full Text] [Related]

  • 14. Approaches to the treatment of chronic myeloid leukemia.
    Savage DG, Goldman JM.
    Int J Hematol; 1994 Jul 04; 60(1):1-21. PubMed ID: 7919235
    [Abstract] [Full Text] [Related]

  • 15. [Autologous hemopoietic stem cell transplantation in treatment of chronic myelogenous leukemia].
    Sacha T, Hawrylecka D, Skotnicki AB.
    Przegl Lek; 1999 Jul 04; 56 Suppl 1():62-6. PubMed ID: 10494185
    [Abstract] [Full Text] [Related]

  • 16. [Intermittent administration of natural interferon-alpha for over 5 years induced complete suppression of Philadelphia chromosome in a patient with myelogenous leukemia].
    Koyama S, Aoki S, Furukawa T, Takahashi M, Kishi K, Koike T, Moriyama Y, Hattori A, Shibata A.
    Rinsho Ketsueki; 1991 Dec 04; 32(12):1577-9. PubMed ID: 1779460
    [Abstract] [Full Text] [Related]

  • 17. The impact of the combination of baseline risk group and cytogenetic response on the survival of patients with chronic myeloid leukemia treated with interferon alpha.
    Hasford J, Pfirrmann M, Shepherd P, Guilhot J, Hehlmann R, Mahon FX, Kluin-Nelemans HC, Ohnishi K, Steegmann JL, Thaler J.
    Haematologica; 2005 Mar 04; 90(3):335-40. PubMed ID: 15749665
    [Abstract] [Full Text] [Related]

  • 18. [Interferon-alpha in the treatment of chronic myeloid leukemia].
    Guilhot F.
    Rev Prat; 1999 Mar 01; 49(5):464-6. PubMed ID: 10358394
    [No Abstract] [Full Text] [Related]

  • 19. Treatment choices in chronic myelogenous leukemia.
    Ready N, Freeman NJ, Carvalho A.
    Hosp Pract (Off Ed); 1992 Sep 30; 27(9A):95-8, 101. PubMed ID: 1522171
    [No Abstract] [Full Text] [Related]

  • 20. Monitoring treatment and survival in chronic myeloid leukemia. Italian Cooperative Study Group on Chronic Myeloid Leukemia and Italian Group for Bone Marrow Transplantation.
    J Clin Oncol; 1999 Jun 30; 17(6):1858-68. PubMed ID: 10561226
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.